Canaccord raised the firm’s price target on Prestige Consumer to $80 from $79 and keeps a Buy rating on the shares. The firm noted they posted earnings and guidance ahead of expectations as management continues to execute on their long-term financial goals, showcase their leadership positioning with their brands with volume growth through 2024.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on PBH:
- Prestige Consumer Healthcare Begins Sharing Financial Results
- Prestige Consumer raises FY24 EPS view to $4.33 from $4.27-$4.32
- Prestige Consumer Healthcare Inc. Reports Third Quarter Fiscal 2024 Results
- Prestige Consumer reports Q3 EPS $1.06, consensus $1.04
- PBH Upcoming Earnings Report: What to Expect?
